Camlin Fine Sciences has informed that a meeting of the QIP Committee (the ‘Committee’) will be held on July 01, 2016, to consider and approve the closure of the QIP; to approve the issue price including a discount, if any thereto as permitted under the SEBI ICDR Regulations for the Equity Shares to be allotted to qualified institutional buyers pursuant to the QIP; and to approve and adopt the placement document in connection with the QIP.
The above information is a part of company’s filings submitted to BSE.
